A secondary qualitative analysis of stakeholder views about participant recruitment, retention, and adherence in decentralised clinical trials (DCTs).
Adherence
DCT
Decentralised clinical trials
Qualitative interviews
Recruitment
Retention
Virtual trials
Journal
Trials
ISSN: 1745-6215
Titre abrégé: Trials
Pays: England
ID NLM: 101263253
Informations de publication
Date de publication:
30 Jul 2022
30 Jul 2022
Historique:
received:
22
03
2022
accepted:
06
07
2022
entrez:
30
7
2022
pubmed:
31
7
2022
medline:
3
8
2022
Statut:
epublish
Résumé
Decentralised clinical trials (DCTs) are clinical trials where all or most trial activities occur in or near participants' homes instead of hospitals or research sites. While more convenient for participants, DCTs may offer limited opportunities to build trust with investigators and trial teams. This qualitative analysis explored DCT stakeholder views to inform strategies for maximising participant recruitment, retention, and adherence. A secondary analysis of original interview transcripts focused on participant engagement: recruitment, retention, and adherence. Semi-structured interviews were conducted with a purposive sample of stakeholders, including trial managers and administrators, investigators, nurses, vendors, and patient representatives. Interview data were coded using a thematic approach to generate descriptive themes. Forty-eight stakeholders were interviewed. Three components of participant engagement in DCTs were identified: identifying and attracting potential participants, retaining participants and encouraging adherence, and involvement of patients and the public. Interviewees believed that a potential participant's beliefs about research value and their trust in the research team strongly influenced the likelihood of taking part in a DCT. Early involvement of patients was identified as one way to gauge participant priorities. However, perceived burden was seen as a barrier to recruitment. Factors influencing retention and adherence were related to the same underlying motivators that drove recruitment: personal values, circumstances, and burden. Being part of a DCT should not conflict with the original motivations to participate. Recruitment, retention, and adherence in DCTs are driven by factors that have previously been found to affect conventional clinical trials. Increasing patient and public involvement can address many of these factors. In contrast to conventional trials, DCTs are perceived as requiring greater emphasis on communication, and contact, to engender trust between participants and researchers despite a relative lack of in-person interaction.
Sections du résumé
BACKGROUND
BACKGROUND
Decentralised clinical trials (DCTs) are clinical trials where all or most trial activities occur in or near participants' homes instead of hospitals or research sites. While more convenient for participants, DCTs may offer limited opportunities to build trust with investigators and trial teams. This qualitative analysis explored DCT stakeholder views to inform strategies for maximising participant recruitment, retention, and adherence.
METHODS
METHODS
A secondary analysis of original interview transcripts focused on participant engagement: recruitment, retention, and adherence. Semi-structured interviews were conducted with a purposive sample of stakeholders, including trial managers and administrators, investigators, nurses, vendors, and patient representatives. Interview data were coded using a thematic approach to generate descriptive themes.
RESULTS
RESULTS
Forty-eight stakeholders were interviewed. Three components of participant engagement in DCTs were identified: identifying and attracting potential participants, retaining participants and encouraging adherence, and involvement of patients and the public. Interviewees believed that a potential participant's beliefs about research value and their trust in the research team strongly influenced the likelihood of taking part in a DCT. Early involvement of patients was identified as one way to gauge participant priorities. However, perceived burden was seen as a barrier to recruitment. Factors influencing retention and adherence were related to the same underlying motivators that drove recruitment: personal values, circumstances, and burden. Being part of a DCT should not conflict with the original motivations to participate.
CONCLUSION
CONCLUSIONS
Recruitment, retention, and adherence in DCTs are driven by factors that have previously been found to affect conventional clinical trials. Increasing patient and public involvement can address many of these factors. In contrast to conventional trials, DCTs are perceived as requiring greater emphasis on communication, and contact, to engender trust between participants and researchers despite a relative lack of in-person interaction.
Identifiants
pubmed: 35907888
doi: 10.1186/s13063-022-06521-4
pii: 10.1186/s13063-022-06521-4
pmc: PMC9338512
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
614Subventions
Organisme : Innovative Medicines Initiative
ID : H2020-JTI-IMI2, grant no. 831458
Informations de copyright
© 2022. The Author(s).
Références
Clin Trials. 2018 Feb;15(1_suppl):19-22
pubmed: 29452519
BMC Health Serv Res. 2014 Feb 26;14:89
pubmed: 24568690
N Engl J Med. 2019 Nov 14;381(20):1909-1917
pubmed: 31722151
Cochrane Database Syst Rev. 2021 Mar 6;3:MR000032
pubmed: 33675536
Res Involv Engagem. 2018 May 22;4:17
pubmed: 29796308
J Clin Transl Sci. 2021 Aug 19;5(1):e194
pubmed: 34888064
Int J Qual Health Care. 2007 Dec;19(6):349-57
pubmed: 17872937
Br J Clin Pharmacol. 2022 Jun;88(6):2843-2862
pubmed: 34961991
Value Health. 2020 Jun;23(6):677-688
pubmed: 32540224
Trials. 2020 Mar 12;21(1):259
pubmed: 32164790
Cochrane Database Syst Rev. 2018 Feb 22;2:MR000013
pubmed: 29468635
Ther Innov Regul Sci. 2020 Jan;54(1):103-116
pubmed: 32008233
Clin Trials. 2021 Aug;18(4):457-465
pubmed: 34011179
NPJ Digit Med. 2019 Dec 12;2:126
pubmed: 31872066